Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
5.11
+0.70 (15.87%)
At close: Mar 9, 2026, 4:00 PM EDT
5.10
-0.01 (-0.20%)
After-hours: Mar 9, 2026, 7:52 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-223.12-258.75-245.6-221.86-169.07
Upgrade
Depreciation & Amortization
11.039.387.16.275.37
Upgrade
Other Amortization
----0.75
Upgrade
Asset Writedown & Restructuring Costs
0.26-0.890.240.26
Upgrade
Loss (Gain) From Sale of Investments
-6.97-8.07-10.170.132.89
Upgrade
Stock-Based Compensation
37.0643.9239.4131.0129.24
Upgrade
Other Operating Activities
--1.88-0.36-12.78
Upgrade
Change in Accounts Payable
-10.356.0710.159.67-4.83
Upgrade
Change in Other Net Operating Assets
2.09-0.43.68-3.61.44
Upgrade
Operating Cash Flow
-190.01-209.72-194.92-178.14-121.16
Upgrade
Capital Expenditures
-0.44-5.86-16.44-8.36-7.62
Upgrade
Cash Acquisitions
---42.73-
Upgrade
Investment in Securities
104.21137.57-81.59-103.4326.57
Upgrade
Other Investing Activities
---0.04-0.26-0.1
Upgrade
Investing Cash Flow
103.77131.71-98.07-69.3318.85
Upgrade
Issuance of Common Stock
-185.74208.4155.3437.68
Upgrade
Repurchase of Common Stock
-0.07---0.05-
Upgrade
Other Financing Activities
0.22----
Upgrade
Financing Cash Flow
0.15185.74208.4155.2937.68
Upgrade
Net Cash Flow
-86.1107.72-84.58-92.18-64.63
Upgrade
Free Cash Flow
-190.45-215.59-211.35-186.5-128.78
Upgrade
Free Cash Flow Per Share
-1.71-2.27-2.52-2.74-2.04
Upgrade
Cash Interest Paid
----0.15
Upgrade
Levered Free Cash Flow
-104.85-133.26-119.77-99.45-82.57
Upgrade
Unlevered Free Cash Flow
-103.67-132.08-118.6-98.29-81.47
Upgrade
Change in Working Capital
-8.265.6713.826.08-3.39
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.